Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1800 participants.
Also called NCT03740971
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,800 participants
- Registry
-
NCT03740971
-
- Other papers using this trial's data
- Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke: The RICAMIS Randomized Clinical Trial
- Platelet-to-Neutrophil Ratio and Efficacy of Remote Ischemic Conditioning in Acute Ischemic Stroke
- Remote Ischemic Conditioning and Outcomes in Acute Ischemic Stroke With Versus Without Large Artery Atherosclerosis
- Renal Function and Efficacy of Remote Ischemic Conditioning in Acute Moderate Ischemic Stroke: A Post Hoc Analysis of RICAMIS Trial
- Smoking status and the efficacy of remote ischaemic conditioning: a secondary analysis of the RICAMIS trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03740971. Randomized; no masking; primary purpose treatment. Start 2018-12-26 (actual); primary completion 2021-04-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke
- Acronym
- RICAMIS
- Condition
- Stroke
- Intervention (Device)
- Remote Ischemic Conditioning treatment
- Intervention (Drug)
- Guideline-based therapy
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct03740971- Content hash
a7afbf7576679a9ab343b42e59054a9f6e2dbaf14927342309e0eb400e484e13